Joel Isaacson & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Buy |
86,319
+1,674
| +2% | +$43.8K | 0.06% | 137 |
|
|
2026
Q1 | $2.38M | Sell |
84,645
-817
| -1% | -$21.8K | 0.08% | 116 |
|
|
2025
Q4 | $2.13M | Buy |
85,462
+5,660
| +7% | +$143K | 0.07% | 126 |
|
|
2025
Q3 | $2.03M | Buy |
79,802
+3,089
| +4% | +$76.2K | 0.07% | 124 |
|
|
2025
Q2 | $1.86M | Sell |
76,713
-6,285
| -8% | -$147K | 0.08% | 116 |
|
|
2025
Q1 | $2.1M | Sell |
82,998
-675
| -0.8% | -$17.7K | 0.1% | 97 |
|
|
2024
Q4 | $2.22M | Buy |
83,673
+6,028
| +8% | +$164K | 0.1% | 98 |
|
|
2024
Q3 | $2.25M | Buy |
77,645
+1,687
| +2% | +$49.2K | 0.11% | 92 |
|
|
2024
Q2 | $2.13M | Buy |
75,958
+141
| +0.2% | +$3.88K | 0.11% | 85 |
|
|
2024
Q1 | $2.1M | Buy |
75,817
+4,395
| +6% | +$122K | 0.12% | 84 |
|
|
2023
Q4 | $2.06M | Buy |
71,422
+21,336
| +43% | +$645K | 0.13% | 80 |
|
|
2023
Q3 | $1.66M | Buy |
50,086
+718
| +1% | +$25.4K | 0.11% | 81 |
|
|
2023
Q2 | $1.81M | Sell |
49,368
-3,001
| -6% | -$117K | 0.12% | 78 |
|
|
2023
Q1 | $2.14M | Sell |
52,369
-835
| -2% | -$36.1K | 0.15% | 67 |
|
|
2022
Q4 | $2.73M | Buy |
53,204
+876
| +2% | +$42K | 0.21% | 53 |
|
|
2022
Q3 | $2.29M | Buy |
52,328
+3,351
| +7% | +$163K | 0.2% | 54 |
|
|
2022
Q2 | $2.57M | Sell |
48,977
-683
| -1% | -$34.8K | 0.22% | 50 |
|
|
2022
Q1 | $2.57M | Buy |
49,660
+793
| +2% | +$41.1K | 0.19% | 54 |
|
|
2021
Q4 | $2.89M | Buy |
48,867
+3,384
| +7% | +$168K | 0.2% | 54 |
|
|
2021
Q3 | $1.96M | Buy |
45,483
+48
| +0.1% | +$2.13K | 0.15% | 68 |
|
|
2021
Q2 | $1.78M | Buy |
45,435
+499
| +1% | +$19.4K | 0.14% | 71 |
|
|
2021
Q1 | $1.63M | Sell |
44,936
-709
| -2% | -$25.2K | 0.14% | 68 |
|
|
2020
Q4 | $1.68M | Sell |
45,645
-1,128
| -2% | -$41.4K | 0.16% | 56 |
|
|
2020
Q3 | $1.63M | Buy |
46,773
+2,658
| +6% | +$93.2K | 0.21% | 50 |
|
|
2020
Q2 | $1.37M | Sell |
44,115
-73
| -0.2% | -$2.48K | 0.2% | 59 |
|
|
2020
Q1 | $1.37M | Sell |
44,188
-26,050
| -37% | -$888K | 0.24% | 49 |
|
|
2019
Q4 | $2.61M | Sell |
70,238
-884
| -1% | -$31.5K | 0.34% | 33 |
|
|
2019
Q3 | $2.42M | Sell |
71,122
-6,003
| -8% | -$218K | 0.35% | 35 |
|
|
2019
Q2 | $3.17M | Sell |
77,125
-20,358
| -21% | -$808K | 0.46% | 28 |
|
|
2019
Q1 | $3.93M | Buy |
97,483
+28,875
| +42% | +$1.16M | 0.57% | 27 |
|
|
2018
Q4 | $2.79M | Buy |
68,608
+28,519
| +71% | +$1.18M | 0.44% | 29 |
|
|
2018
Q3 | $1.68M | Sell |
40,089
-1,430
| -3% | -$55K | 0.26% | 40 |
|
|
2018
Q2 | $1.43M | Sell |
41,519
-180
| -0.4% | -$6.15K | 0.24% | 43 |
|
|
2018
Q1 | $1.4M | Buy |
41,699
+2,983
| +8% | +$103K | 0.24% | 44 |
|
|
2017
Q4 | $1.33M | Buy |
38,716
+1,374
| +4% | +$46.9K | 0.23% | 48 |
|
|
2017
Q3 | $1.26M | Buy |
37,342
+892
| +2% | +$28.7K | 0.23% | 49 |
|
|
2017
Q2 | $1.16M | Sell |
36,450
-254
| -0.7% | -$8.01K | 0.22% | 51 |
|
|
2017
Q1 | $1.19M | Buy |
36,704
+57
| +0.2% | +$1.8K | 0.23% | 50 |
|
|
2016
Q4 | $1.13M | Sell |
36,647
-3,264
| -8% | -$99.6K | 0.23% | 49 |
|
|
2016
Q3 | $1.28M | Sell |
39,911
-1,105
| -3% | -$36.9K | 0.26% | 38 |
|
|
2016
Q2 | $1.37M | Buy |
41,016
+350
| +0.9% | +$11.2K | 0.29% | 36 |
|
|
2016
Q1 | $1.14M | Sell |
40,666
-804
| -2% | -$23K | 0.25% | 43 |
|
|
2015
Q4 | $1.27M | Sell |
41,470
-3,036
| -7% | -$95.5K | 0.31% | 41 |
|
|
2015
Q3 | $1.33M | Buy |
44,506
+874
| +2% | +$28K | 0.35% | 37 |
|
|
2015
Q2 | $1.39M | Buy |
43,632
+3,099
| +8% | +$101K | 0.36% | 36 |
|
|
2015
Q1 | $1.34M | Buy |
40,533
+672
| +2% | +$21.4K | 0.34% | 40 |
|
|
2014
Q4 | $1.18M | Buy |
39,861
+8,181
| +26% | +$235K | 0.32% | 40 |
|
|
2014
Q3 | $889K | Buy |
31,680
+918
| +3% | +$25.8K | 0.27% | 47 |
|
|
2014
Q2 | $866K | Sell |
30,762
-439
| -1% | -$12.5K | 0.27% | 47 |
|
|
2014
Q1 | $951K | Buy |
31,201
+1,883
| +6% | +$56.1K | 0.32% | 42 |
|
|
2013
Q4 | $852K | Buy |
29,318
+1,295
| +5% | +$37.7K | 0.31% | 40 |
|
|
2013
Q3 | $764K | Buy |
28,023
+8,797
| +46% | +$239K | 0.31% | 42 |
|
|
2013
Q2 | $511K | Buy |
+19,226
| New | +$531K | 0.24% | 49 |
|
Other funds holding PFE
Joel Isaacson & Co's PFE Position: Q2 2026 in Review
Joel Isaacson & Co increased its Pfizer (PFE) stake by 2% in Q2 2026, buying an estimated $43.8K and bringing the position to 86,319 shares worth $2.08M. The position accounts for 0.06% of the portfolio, ranked #137.
Joel Isaacson & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.93M in Q1 2019. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Joel Isaacson & Co held 86,319 shares of Pfizer worth $2.08M as of Q2 2026.
- Joel Isaacson & Co bought 1,674 Pfizer shares in Q2 2026, an estimated $43.8K.
- Pfizer made up 0.06% of Joel Isaacson & Co's portfolio in Q2 2026, its #137 holding.
- Joel Isaacson & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Joel Isaacson & Co's Pfizer position peaked at $3.93M in Q1 2019.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.